Neuroscience Education Institute

Quote for "exact phrases"

All Activities only Prescriber's Guide

Activity Type

Topic

With Credit only

Guest activities only

Sort order: Newest to oldest Alphabetical by title

Results 1 - 50 of 1109

	FDA Approves Cyclobenzaprine For Fibromyalgia in Adults This Month in Psychpharmacology added 08/15/2025. CME credit is not available
	Increased Prescribing of ADHD Medication and Real-World Outcomes Over Time This Month in Psychpharmacology added 08/11/2025. CME credit is not available
	Oldest-Old Respond Better to ECT Than Younger Adults, Study Finds This Month in Psychpharmacology added 08/11/2025. CME credit is not available
	Esketamine Monotherapy in Adults With Treatment-Resistant Depression This Month in Psychpharmacology added 07/29/2025. CME credit is not available
	Dementia Management for Psychiatric Practitioners MPP: Articles added 07/29/2025. CME credit is available
	Antidepressant Discontinuation Symptoms This Month in Psychpharmacology added 07/28/2025. CME credit is not available
	The Relevance of Insomnia Among Healthcare Workers This Month in Psychpharmacology added 07/22/2025. CME credit is not available
	20-Year Study of PTSD in World Trade Center Responders This Month in Psychpharmacology added 07/21/2025. CME credit is not available
	Paternal Perinatal Depression, Anxiety, and Stress and Child Development This Month in Psychpharmacology added 07/14/2025. CME credit is not available
	Early Post-Stroke Counseling Tied to Lower Rates of Anxiety and Depression This Month in Psychpharmacology added 07/14/2025. CME credit is not available
	Lithium Versus Quetiapine Augmentation For Treatment-Resistant Depression This Month in Psychpharmacology added 07/08/2025. CME credit is not available
	New Study Links Psychiatric Medications to Increased Risk of Amyotrophic Lateral Sclerosis This Month in Psychpharmacology added 07/08/2025. CME credit is not available
	Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings This Month in Psychpharmacology added 07/08/2025. CME credit is not available
	Benzgalantamine Approved For The Treatment Of Mild-To-Moderate Alzheimer’s Disease This Month in Psychpharmacology added 06/27/2025. CME credit is not available
	Fremanezumab Offers Dual Relief for Patients with Migraine and Major Depression This Month in Psychpharmacology added 06/25/2025. CME credit is not available
	Esketamine Combinations in TRD: SNRI vs SSRI Outcomes This Month in Psychpharmacology added 06/25/2025. CME credit is not available
	Psilocybin and Escitalopram Show Distinct Brain Effects in Depression Treatment This Month in Psychpharmacology added 06/06/2025. CME credit is not available
	Stimulant Medication Use and Risk of Psychotic Experiences This Month in Psychpharmacology added 06/06/2025. CME credit is not available
	Valbenazine in Elderly Adults with Tardive Dyskinesia This Month in Psychpharmacology added 06/04/2025. CME credit is not available
	Comparative Cardiovascular Safety of ADHD Medications This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	Molecular Pathways of Ketamine This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	Trial Results of Solriamfetol in MDD With/Without Excessive Daytime Sleepiness This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	Efficacy and Safety of Brexpiprazole in Adolescents with Schizophrenia This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	High Rates of Comorbid Depression, Anxiety in Chronic Pain This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	Magnetic Stimulation to the Precuneus Shows Benefit in Alzheimer’s Patients This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	Postpartum Hormonal Contraceptive Use and Risk of Depression This Month in Psychpharmacology added 05/28/2025. CME credit is not available
	NEI Spring Congress Highlights: Navigating Dissociative Disorders This Month in Psychpharmacology added 05/12/2025. CME credit is not available
	NEI Spring Congress Highlights: GLP-1s and Brain Health – Beyond Weight Loss This Month in Psychpharmacology added 05/12/2025. CME credit is not available
	Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults This Month in Psychpharmacology added 04/23/2025. CME credit is not available
	Want to Help Your Patients with Food Allergy Anxiety? This Month in Psychpharmacology added 04/17/2025. CME credit is not available
	Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression This Month in Psychpharmacology added 04/15/2025. CME credit is not available
	Predicting Suicidal Behaviors in Preadolescents This Month in Psychpharmacology added 04/15/2025. CME credit is not available
	Glutamatergic Medications Show Promise for Obsessive-Compulsive and Related Disorders This Month in Psychpharmacology added 04/04/2025. CME credit is not available
	Antidepressant Use Before, During, and After Pregnancy This Month in Psychpharmacology added 04/02/2025. CME credit is not available
	New Research Links Depression to Increased Risk of Multiple Chronic Diseases This Month in Psychpharmacology added 03/28/2025. CME credit is not available
	Rheumatoid Arthritis Linked to Faster Cognitive Decline in Dementia Patient This Month in Psychpharmacology added 03/28/2025. CME credit is not available
	Study Demonstrates Success in Shifting Adolescent Sleep Patterns Through Targeted Interventions This Month in Psychpharmacology added 03/13/2025. CME credit is not available
	FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment This Month in Psychpharmacology added 03/11/2025. CME credit is not available
	Deprescribing Antidepressants in Children and Adolescents This Month in Psychpharmacology added 03/04/2025. CME credit is not available
	New Insights into Esketamine Treatment: Efficacy, Safety, and Long-Term Effects This Month in Psychpharmacology added 03/04/2025. CME credit is not available
	Once-Weekly Semaglutide in Adults With Alcohol Use Disorder This Month in Psychpharmacology added 02/28/2025. CME credit is not available
	Population Study Reveals Most Effective Antipsychotic Strategies for First-Episode Schizophrenia This Month in Psychpharmacology added 02/16/2025. CME credit is not available
	Metformin Tips and Pearls added 02/13/2025. CME credit is not available
	Social Determinants of Health and Suicide-Related Outcomes This Month in Psychpharmacology added 02/12/2025. CME credit is not available
	Associations Between Biomarkers of Inflammation and Depressive Symptoms This Month in Psychpharmacology added 02/12/2025. CME credit is not available
	Depressive Symptoms and Amyloid Pathology This Month in Psychpharmacology added 02/12/2025. CME credit is not available
	From Assessment to Intervention: Evidence-Based Approaches in Tardive Dyskinesia CNS Spectrums added 02/12/2025. CME credit is available
	Current Solutions: Electrical Stimulation Techniques for Depression MPP: Articles added 02/04/2025. CME credit is available
	Label Update for Viloxazine ER: New Pharmacodynamic Data and Breastfeeding Info This Month in Psychpharmacology added 01/27/2025. CME credit is not available
<< Back 1 2 3 4 5 6 7 8 9 10 ... Next >>